Cargando…

A Pilot Study of Tranilast for Cardiomyopathy of Muscular Dystrophy

OBJECTIVE: Heart failure is currently the most serious complication of muscular dystrophy. The transient receptor potential cation channel, subfamily V, member 2 (TRPV2) is a stretch-sensitive Ca channel. In damaged myocytes or cardiomyocytes, TRPV2 translocates to the cytoplasmic membrane and enhan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsumura, Tsuyoshi, Matsui, Misa, Iwata, Yuko, Asakura, Masanori, Saito, Toshio, Fujimura, Harutoshi, Sakoda, Saburo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827307/ https://www.ncbi.nlm.nih.gov/pubmed/29093384 http://dx.doi.org/10.2169/internalmedicine.8651-16

Ejemplares similares

Reply to “The Effects of Tranilast on Cardiomyopathy in Becker Muscular Dystrophy Requires Profound Cardiac and Neurologic Evaluations”
por: Matsumura, Tsuyoshi, et al.
Publicado: (2018)

The experiences of patients with Duchenne muscular dystrophy in facing and learning about their clinical conditions
por: Fujino, Haruo, et al.
Publicado: (2016)

Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
por: Matsumura, Tsuyoshi, et al.
Publicado: (2022)

Impact of the TRPV2 Inhibitor on Advanced Heart Failure in Patients with Muscular Dystrophy: Exploratory Study of Biomarkers Related to the Efficacy of Tranilast
por: Takahashi, Chisato, et al.
Publicado: (2023)

Blockade of TRPV2 is a Novel Therapy for Cardiomyopathy in Muscular Dystrophy
por: Iwata, Yuko, et al.
Publicado: (2019)

The Effects of Tranilast on Cardiomyopathy in Becker Muscular Dystrophy Requires Profound Cardiac and Neurologic Evaluations
por: Stöllberger, Claudia, et al.
Publicado: (2018)

Questionnaire survey on the impact of coronavirus disease 2019 on patients with muscular dystrophy
por: Matsumura, Tsuyoshi, et al.
Publicado: (2021)

Parkinsonian Rigidity Depends on the Velocity of Passive Joint Movement
por: Endo, Takuyuki, et al.
Publicado: (2015)

Psychological Case Conference Following the Death of a Patient With Neuromuscular Disease: A Source of Emotional Support for Participating Medical Staff
por: Fujino, Haruo, et al.
Publicado: (2019)

Safety and immunogenicity of mRNA COVID‐19 vaccine in inpatients with muscular dystrophy
por: Saito, Tomoko, et al.
Publicado: (2022)

Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy
por: Verma, Mayank, et al.
Publicado: (2019)

Cardiac Dysrhythmias, Cardiomyopathy and Muscular Dystrophy in Patients with Emery-Dreifuss Muscular Dystrophy and Limb-Girdle Muscular Dystrophy Type 1B
por: Hong, Jong-Seo, et al.
Publicado: (2005)

Uricosuric targets of tranilast
por: Mandal, Asim K., et al.
Publicado: (2017)

Differences in splicing defects between the grey and white matter in myotonic dystrophy type 1 patients
por: Nishi, Masamitsu, et al.
Publicado: (2020)

Parkinsonian Rigidity Shows Variable Properties Depending on the Elbow Joint Angle
por: Endo, Takuyuki, et al.
Publicado: (2013)

Implications of notch signaling in duchenne muscular dystrophy
por: Den Hartog, Lily, et al.
Publicado: (2022)

Fukuyama-type congenital muscular dystrophy and defective glycosylation of α-dystroglycan
por: Saito, Fumiaki, et al.
Publicado: (2011)

Vascular therapy for Duchenne muscular dystrophy (DMD)
por: Thapa, Sangharsha, et al.
Publicado: (2023)

Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy
por: Barp, Andrea, et al.
Publicado: (2015)

Echocardiographic Features of Cardiomyopathy in Emery-Dreifuss Muscular Dystrophy
por: Marchel, Michał, et al.
Publicado: (2021)

Vascular-targeted therapies for Duchenne muscular dystrophy
por: Ennen, James P, et al.
Publicado: (2013)

Development of Sustained-Release Ophthalmic Formulation Based on Tranilast Solid Nanoparticles
por: Minami, Misa, et al.
Publicado: (2020)

Angiogenesis as a novel therapeutic strategy for Duchenne muscular dystrophy through decreased ischemia and increased satellite cells
por: Shimizu-Motohashi, Yuko, et al.
Publicado: (2014)

Noisy Interlimb Coordination Can Be a Main Cause of Freezing of Gait in Patients with Little to No Parkinsonism
por: Tanahashi, Takao, et al.
Publicado: (2013)

Tranilast Inhibits Pulmonary Fibrosis by Suppressing TGFβ/SMAD2 Pathway
por: Kato, Motoyasu, et al.
Publicado: (2020)

Quality of life and subjective symptom impact in Japanese patients with myotonic dystrophy type 1
por: Fujino, Haruo, et al.
Publicado: (2022)

Viltolarsen in Japanese Duchenne muscular dystrophy patients: A phase 1/2 study
por: Komaki, Hirofumi, et al.
Publicado: (2020)

Predictors of Death in Adults With Duchenne Muscular Dystrophy–Associated Cardiomyopathy
por: Cheeran, Daniel, et al.
Publicado: (2017)

A case of Becker muscular dystrophy with early manifestation of cardiomyopathy
por: Doo, Ki Hyun, et al.
Publicado: (2012)

Becker muscular dystrophy with dilated cardiomyopathy: A case report
por: Chen, Yongliang, et al.
Publicado: (2021)

Cardiomyopathy in Duchenne Muscular Dystrophy: A Single-Center Experience
por: Kummitha, Karthikeyan, et al.
Publicado: (2022)

Pregnancy-Induced Amelioration of Muscular Dystrophy Phenotype in mdx Mice via Muscle Membrane Stabilization Effect of Glucocorticoid
por: Shimizu-Motohashi, Yuko, et al.
Publicado: (2015)

Early phase 2 trial of TAS‐205 in patients with Duchenne muscular dystrophy
por: Komaki, Hirofumi, et al.
Publicado: (2020)

Current Understanding of Molecular Pathology and Treatment of Cardiomyopathy in Duchenne Muscular Dystrophy
por: van Westering, Tirsa L. E., et al.
Publicado: (2015)

Cardiomyopathy in limb girdle muscular dystrophy R9, FKRP related
por: Libell, Eric M., et al.
Publicado: (2020)

Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy
por: Guo, Lee‐Jae, et al.
Publicado: (2019)

Natural History of Histopathologic Changes in Cardiomyopathy of Golden Retriever Muscular Dystrophy
por: Schneider, Sarah M., et al.
Publicado: (2022)

Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel
por: Spurney, Christopher F, et al.
Publicado: (2021)

Pachydermodactyly Treated with Tranilast in a Young Girl
por: Higuchi, Chikahisa, et al.
Publicado: (2014)

Tranilast enhances the effect of anticancer agents in osteosarcoma
por: Nakashima, Takayuki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uokgblli8r6h60fr9pa1bcb3cl